What is MOXIFLOXACIN OPHTHALMIC SOLUTION used for?

MOXIFLOXACIN OPHTHALMIC SOLUTION (brand name Moxifloxacin ophthalmic solution) is a Fluoroquinolone Antibiotic indicated for Micrococcus luteus*, Staphylococcus aureus, Staphylococcus epidermidis.

What are the most common side effects of MOXIFLOXACIN OPHTHALMIC SOLUTION?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for MOXIFLOXACIN OPHTHALMIC SOLUTION. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is MOXIFLOXACIN OPHTHALMIC SOLUTION the same as Moxifloxacin ophthalmic solution?

Moxifloxacin ophthalmic solution is a brand name for MOXIFLOXACIN OPHTHALMIC SOLUTION. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

MOXIFLOXACIN OPHTHALMIC SOLUTION

Q: How does MOXIFLOXACIN OPHTHALMIC SOLUTION work?

MOXIFLOXACIN OPHTHALMIC SOLUTION works through the following mechanism: 12.1 Mechanism of Action Moxifloxacin is a member of the fluoroquinolone class of anti-infective drugs (See 12.4 Microbiology)..

Fluoroquinolone Antibiotic

Brand names: Moxifloxacin ophthalmic solution

Ophthalmic

Mechanism of Action

12.1 Mechanism of Action Moxifloxacin is a member of the fluoroquinolone class of anti-infective drugs (See 12.4 Microbiology).

Indications

Micrococcus luteus*

Staphylococcus aureus

Staphylococcus epidermidis

Staphylococcus haemolyticus

Staphylococcus hominis

Staphylococcus warneri*

Contraindications

• 4 CONTRAINDICATIONS Moxifloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to moxifloxacin
• to other quinolones
• or to any of the components in this medication. MOXIFLOXACIN ophthalmic solution is contraindicated in patients with a history of hypersensitivity to MOXIFLOXACIN
• to other quinolones
• or to any of the components in this medication.

FDA Warnings

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions : Hypersensitivity and anaphylaxis have been reported with systemic use of MOXIFLOXACIN
1 Hypersensitivity Reactions In patients receiving systemically administered quinolones, including moxifloxacin, serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported, some following the first dose
Serious acute hypersensitivity reactions may require immediate emergency treatment

Known Side Effects

9 documented side effects by frequency

Shortness of Breath

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Rash

1-10%

Fatigue

1-10%

General Unwellness

0.1-1%

Fever

0.1-1%

Nausea

0.1-1%

Condition Worsened

0.1-1%

Community Discussions

No community discussions found for MOXIFLOXACIN OPHTHALMIC SOLUTION yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → MOXIFLOXACIN OPHTHALMIC SOLUTION openFDA label JSON → MOXIFLOXACIN OPHTHALMIC SOLUTION FAERS adverse-event reports → MOXIFLOXACIN OPHTHALMIC SOLUTION ClinicalTrials.gov → completed Phase 2+ trials of MOXIFLOXACIN OPHTHALMIC SOLUTION

Compare With

11 available comparisons

Formulations

Dosage Forms

Tablet

Route

Ophthalmic